Target Name: GALT
NCBI ID: G2592
Other Name(s): Uridylyl removing enzyme | Galactose-1-phosphate uridylyltransferase | Gal-1-P uridylyltransferase | galactose-1-phosphate uridylyltransferase | Hexose-1-phosphate uridylyltransferase | Uridyl transferase | Galactose-1-phosphate uridylyltransferase, transcript variant 1 | UDP-glucose--hexose-1-phosphate uridylyltransferase | Galactose-1-phosphate uridyl transferase | gal-1-P uridylyltransferase | galactose-1-phosphate uridyl transferase | GALT variant 1 | GALT_HUMAN | Galactose-1-phosphate uridylyltransferase (isoform 1)

Understanding GALT: Enzyme, Drug Target and Biomarker for Uridine and Harmful Substances

GALT (Uridylyl removing enzyme) is a protein that is expressed in various tissues throughout the body, including the liver, pancreas, and blood cells. It is involved in the metabolism of uridine, which is a nucleotide base that is synthesized from DNA and RNA and is found in many compounds, including drugs, toxins, and waste products.

GALT is a critical enzyme that helps regulate the levels of uridine in the body. It is able to remove uridine from the body's cells and thus helps to maintain a balance of this important compound. In addition, GALT is involved in the detoxification of many harmful substances, such as drugs and toxins, which can be found in the body.

GALT is also a potential drug target. Many drugs work by inhibiting the activity of GALT, which can lead to the accumulation of uridine in the body and can cause a variety of negative side effects. Therefore, researchers are interested in developing drugs that can specifically target GALT to treat a variety of diseases.

One of the challenges in studying GALT is its complex structure. GALT is a protein that is composed of multiple domains, including an N-terminus, a catalytic core, and a C-terminus. The N-terminus of GALT contains a putative transmembrane domain that is involved in the protein's localization and stability. The catalytic core of GALT contains a Rossmann-fold, which is a structural motif that is commonly found in proteins that are involved in enzyme-mediated reactions. The C-terminus of GALT contains a variable region that is involved in the protein's stability and interactions with other proteins.

In addition to its structure, GALT's function is also regulated by its subcellular localization. GALT is predominantly expressed in the liver, pancreas, and blood cells, but it is also found in other tissues, such as the kidneys and the intestine. The liver is the main site of GALT expression, and it is thought that the pancreas and blood cells may also be involved in its expression.

GALT's role in the detoxification of harmful substances is also regulated by its expression level. In many organisms, GALT is expressed at low levels and is only active in certain cell types or under specific conditions. This allows the body to respond to the presence of harmful substances and to protect itself from their harmful effects.

In addition to its role in the detoxification of harmful substances, GALT may also be involved in the regulation of other cellular processes. For example, GALT has been shown to be involved in the metabolism of the nucleotide base adenine, which is involved in many cellular processes, including DNA replication and gene expression. In addition, GALT may be involved in the regulation of the levels of other nutrients in the body, such as nitrogen and oxygen.

GALT is also a potential biomarker for a variety of diseases. The levels of GALT in the body can be affected by a wide range of factors, including the levels of uridine in the body, the levels of other nutrients, and the presence of certain diseases. Therefore, the analysis of GALT levels may be a useful diagnostic tool for some diseases.

In conclusion, GALT (Uridylyl removing enzyme) is a protein that is involved in the regulation of the levels of uridine in the body and the detoxification of harmful substances. Its structure and function are regulated by multiple factors, including its subcellular localization, its expression level, and its involvement in other cellular processes. In addition, GALT is a potential drug target and a biomarker for a variety of diseases. Further research is needed to fully understand the role of GALT in the body and its potential as a drug or biomarker.

Protein Name: Galactose-1-phosphate Uridylyltransferase

Functions: Plays an important role in galactose metabolism

More Common Targets

Gamma Crystallin | Gamma-Aminobutyric acid type B receptor | Gamma-aminobutyric-acid A receptor, Rho | gamma-delta T Cell Receptor (TCR) Complex | Gamma-glutamyl transferase | gamma-Secretase | Gamma-tubulin complex | GAMT | GAN | GANAB | GANC | Gap junction Connexin ( | Gap Junction Protein | GAP43 | GAPDH | GAPDHP1 | GAPDHP14 | GAPDHP21 | GAPDHP38 | GAPDHP42 | GAPDHP56 | GAPDHP62 | GAPDHP65 | GAPDHP72 | GAPDHS | GAPLINC | GAPT | GAPVD1 | GAR1 | GAREM1 | GAREM2 | GARIN1A | GARIN1B | GARIN2 | GARIN3 | GARIN4 | GARIN5A | GARIN5B | GARIN6 | GARNL3 | GARRE1 | GARS1 | GARS1-DT | GART | GAS1 | GAS1RR | GAS2 | GAS2L1 | GAS2L2 | GAS2L3 | GAS5 | GAS6 | GAS6-AS1 | GAS7 | GAS8 | GAS8-AS1 | GASAL1 | GASK1A | GASK1B | GASK1B-AS1 | GAST | GATA1 | GATA2 | GATA2-AS1 | GATA3 | GATA3-AS1 | GATA4 | GATA5 | GATA6 | GATA6-AS1 | GATAD1 | GATAD2A | GATAD2B | GATB | GATC | GATD1 | GATD1-DT | GATD3 | GATM | GATOR1 Complex | GAU1 | GBA1 | GBA2 | GBA3 | GBAP1 | GBE1 | GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA